Clinical Trials Logo

Dietary Hyperoxaluria clinical trials

View clinical trials related to Dietary Hyperoxaluria.

Filter by:
  • None
  • Page 1

NCT ID: NCT02547805 Completed - Nephrolithiasis Clinical Trials

Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days

Start date: September 2015
Phase: Phase 2
Study type: Interventional

Evaluate the safety, tolerability, and efficacy of 28 days of treatment with ALLN-177 for reducing urinary oxalate excretion in patients with secondary hyperoxaluria and kidney stones.

NCT ID: NCT02503345 Completed - Nephrolithiasis Clinical Trials

Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones

Start date: July 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, and efficacy of different doses of ALLN 177 for reducing urinary oxalate excretion in patients with secondary hyperoxaluria and recurrent kidney stones.